Caffeine induces cardiomyocyte hypertrophy via p300 and CaMKII pathways

Liang Shi1, Hao Xu1, Jinhong Wei1

  • 1The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, People's Republic of China.

Insights

Caffeine causes cardiomyocyte hypertrophy by altering intracellular calcium levels. This process involves the ryanodine receptor (RyR2) and activates signaling pathways leading to cardiac dysfunction.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cell Physiology

Background:

  • Caffeine is known to trigger intracellular calcium release in cardiomyocytes.
  • While caffeine's link to cardiac arrhythmia is established, its precise effects on cardiac function and hypertrophy remain unclear.

Purpose of the Study:

  • To investigate the impact of caffeine on cardiomyocyte hypertrophy.
  • To elucidate the associated intracellular signaling pathways involved in caffeine-induced cardiac changes.

Main Methods:

  • Ventricular myocytes from neonatal Sprague-Dawley rats were incubated with caffeine.
  • Measurements included total protein content, cell surface area, beta-myosin heavy chain (β-MHC) expression, and intracellular calcium (Ca2+) dynamics.
  • The role of cardiac ryanodine receptor (RyR2), CaMKII, and p300 was assessed using specific inhibitors (KN93, curcumin).

Main Results:

  • Caffeine incubation led to increased cardiomyocyte size, protein content, and β-MHC expression.
  • Basal intracellular Ca2+ levels rose, while sarcoplasmic reticulum (SR) Ca2+ content and oscillation amplitude decreased.
  • Inhibition of RyR2, CaMKII (with KN93), or p300 (with curcumin) abolished caffeine-induced hypertrophy and restored physiological Ca2+ levels in SR.

Conclusions:

  • Caffeine induces cardiomyocyte hypertrophy via altered intracellular Ca2+ handling, specifically through SR Ca2+ release.
  • This process activates the CaMKII and p300 signaling cascade, leading to enhanced myocyte enhancer factor-2 (MEF2) expression.
  • Targeting RyR2, CaMKII, or p300 may offer therapeutic strategies for caffeine-induced cardiac dysfunction.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
37
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.8K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.4K